- 関
- Anticoagulation inhibitors
WordNet
- limit, block, or decrease the action or function of; "inhibit the action of the enzyme"; "inhibit the rate of a chemical reaction"
- control and refrain from showing; of emotions, desires, impulses, or behavior (同)bottle up, suppress
- limit the range or extent of; "Contact between the young was inhibited by strict social customs"
- a substance that retards or stops an activity
- the administration of an anticoagulant drug to retard coagulation of the blood
PrepTutorEJDIC
- 《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
- 〈感情・欲望・行動・作用など〉‘を'抑制する / (…しないように)〈人〉‘を'抑制する,妨げる《+『名』+『from』+『名』(do『ing』)》
- 抑制する人(物) / 化学反応抑制剤
- OLD French古[代]フランス語
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.
- Arcelus JI1, Domènech P2, Fernández-Capitan Mdel C3, Guijarro R4, Jiménez D5, Jiménez S6, Lozano FS7, Monreal M8, Nieto JA9, Páramo JA10.
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.Clin Appl Thromb Hemost.2015 May;21(4):297-308. doi: 10.1177/1076029614561321. Epub 2014 Dec 9.
- Anticoagulation therapy is the standard treatment of patients with symptomatic venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. Until recently, treatment of VTE was based on parenteral or low-molecular-weight heparin for initial therapy (5-10 days) and oral vitami
- PMID 25504999
- Periprocedural management of rivaroxaban-treated patients.
- Imberti D1, Ambrosoli A, Cimminiello C, Compagnone C, Fanelli A, Tripodi A, Ottani F.
- Expert opinion on pharmacotherapy.Expert Opin Pharmacother.2015 Apr;16(5):685-91. doi: 10.1517/14656566.2015.1013939. Epub 2015 Feb 17.
- INTRODUCTION: The increasing and widespread use of direct oral anticoagulants (DOACs) demands guidelines and experts' consensus for their rational and safe use, especially in certain situations for which there is no evidence-based consensus, such as the periprocedural setting. Rivaroxaban is an oral
- PMID 25690076
- Hemocompatibility and cytocompatibility of the hirudin-modified silk fibroin.
- Sun D1, Hao Y, Yang G, Wang J.
- Journal of biomedical materials research. Part B, Applied biomaterials.J Biomed Mater Res B Appl Biomater.2015 Apr;103(3):556-62. doi: 10.1002/jbm.b.33241. Epub 2014 Jun 21.
- Hirudin (Hir), a thrombin direct inhibitor, was used to modify a polyethylene glycol diglycidyl ether (PEG-DE) crosslinked regenerated silk fibroin (SF) material to improve hemocompatibility. Hemolysis characteristics, platelet adhesion, platelet activity, and plasma recalcification time were invest
- PMID 24953970
Japanese Journal
- ヘパリン起因性血小板減少症(<特集>血小板減少症とアフェレシス)
- 宮田 茂樹
- 日本アフェレシス学会雑誌 31(1), 41-46, 2012-02-29
- … Immune heparin-induced thrombocytopenia (HIT) is a life-threatening side effect of heparin therapy. … HIT has been better recognized even in Japan since argatroban, a direct thrombin inhibitor, was approved for the indication of HIT in July 2008. … In addition, the indication of argatroban was expanded for HIT patients who undergo hemodialysis or percutaneous coronary intervention in May 2011. …
- NAID 110009327452
- New Insights into Anticoagulation in Atrial Fibrillation
- FAN Xiaohan,ZHANG Shu
- Journal of
- … Oral anticoagulation in atrial fibrillation (AF) is important for stroke prevention. … Warfarin, one of the commonly used vitamin K antagonists (VKAs), is underused in clinical practice due to its well-known limitations and complexity. … Identification of patients at high risk of bleeding and weighing up the embolism and bleeding risk can help to refine anticoagulation to minimize bleeding risk. …
- NAID 10029599127
- Xa阻害活性測定による合成Xa阻害剤モニタリングの試み
- 小野寺 智洋,眞島 任史,笠原 靖彦,松野 一彦,遠見 真理,三浪 明男
- 東日本整形災害外科学会雑誌 = Journal of
- NAID 10029275895
Related Links
- Conclusion The success of fondaparinux in acute settings in vivo is not explained solely by its properties as an fXa inhibitor. We have reported that fIXa contributes to the long term capacity of clot-associated catalysts to restart a ...
- Abstract In our series of synthetic inhibitors of arginine-specific esteroproteases we have identified 1,2-di(5-amidino-2-benzofuranyl)ethane (DABE) as a preferential inhibitor of bovine factor Xa (K i = 5.73 × 10 −7 M) and α,α′-bis(4 ...
★リンクテーブル★
[★]
- 関
- abrogate、block、depress、depression、deter、inhibition、interdict、prevent、prevention、repress、repression、restrain、restraint、suppress、suppression
[★]
- 関
- blocker、depressant、suppressant
[★]
- 関
- anticoagulant